Most of the vaccines in use globally require two doses. Doses administered per 100 people in the total population can not be converted to an accurate percentage easily due to differences in vaccines and/or datasets.
As such, our estimate on percentage world population vaccinated might fluctuate a bit from time to time as we update our calculations and/or datasets.
๐ Global leaderboard by people fully vaccinated per 100 people in the total population
01: ๐ฌ๐ฎ GI 35.78%
02: ๐ฎ๐ฑ IL 33.29%
03: ๐ธ๐จ SC 19.84%
04: ๐ฐ๐พ KY 10.66%
05: ๐ท๐ธ RS 10.21%
06: ๐ฎ๐ฒ IM 5.51%
07: ๐บ๐ธ US 5.09%
08: ๐ฌ๐ฌ GG 4.61%
09: ๐ฒ๐น MT 4.35%
10: ๐ฏ๐ช JE 3.22%
๐ Global leaderboard by people fully vaccinated per 100 people in the total population
11: ๐ฉ๐ฐ DK 3.0%
12: ๐ฎ๐ธ IS 2.95%
13: ๐ท๐ด RO 2.84%
14: ๐ซ๐ด FO 2.5%
15: ๐ช๐ธ ES 2.5%
16: ๐ฑ๐น LT 2.45%
17: ๐ธ๐ฎ SI 2.38%
18: ๐ต๐ฑ PL 2.29%
19: ๐ต๐น PT 2.26%
20: ๐ฎ๐น IT 2.19%
๐ Global leaderboard by people fully vaccinated per 100 people in the total population
21: ๐ฎ๐ช IE 2.14%
22: ๐ง๐ช BE 2.12%
23: ๐ฌ๐ท GR 2.07%
24: ๐ฆ๐น AT 2.05%
25: ๐ฉ๐ช DE 1.95%
26: ๐จ๐ฟ CZ 1.91%
27: ๐ช๐ช EE 1.87%
28: ๐ธ๐ช SE 1.86%
29: ๐ณ๐ด NO 1.72%
30: ๐จ๐พ CY 1.69%
๐ Global leaderboard by people fully vaccinated per 100 people in the total population
31: ๐ธ๐ฐ SK 1.62%
32: ๐จ๐ญ CH 1.59%
33: ๐ญ๐บ HU 1.58%
34: ๐ซ๐ท FR 1.53%
35: ๐ญ๐ท HR 1.34%
36: ๐ซ๐ฎ FI 1.29%
37: ๐ท๐บ RU 1.16%
38: ๐น๐ท TR 1.16%
39: ๐ฑ๐บ LU 1.13%
40: ๐ฑ๐ป LV 0.89%
๐ Global leaderboard by people fully vaccinated per 100 people in the total population
๐ Global leaderboard by doses administered per 100 people in the total population
21: ๐น๐ท TR 7.54
22: ๐ฎ๐ธ IS 7.54
23: ๐จ๐ญ CH 7.07
24: ๐ณ๐ด NO 6.86
25: ๐ฑ๐น LT 6.86
26: ๐ท๐ด RO 6.85
27: ๐ต๐ฑ PL 6.76
28: ๐ธ๐ฎ SI 6.49
29: ๐ฒ๐ฆ MA 6.4
30: ๐ฌ๐ท GR 6.37
๐ Global leaderboard by doses administered per 100 people in the total population
31: ๐ธ๐ฐ SK 6.31
32: ๐ช๐ธ ES 6.28
33: ๐ช๐ช EE 6.21
34: ๐ฒ๐จ MC 6.12
35: ๐ต๐น PT 6.07
36: ๐ซ๐ฎ FI 6.02
37: ๐ฎ๐ช IE 5.95
38: ๐ธ๐ช SE 5.8
39: ๐ฉ๐ช DE 5.63
40: ๐ญ๐บ HU 5.63
๐ Global leaderboard by doses administered per 100 people in the total population
41: ๐ฎ๐น IT 5.6
42: ๐ง๐ช BE 5.44
43: ๐ซ๐ท FR 5.18
44: ๐จ๐พ CY 5.07
45: ๐จ๐ฟ CZ 5.03
46: ๐ฑ๐บ LU 4.62
47: ๐ฌ๐ฑ GL 4.55
48: ๐ธ๐ฌ SG 4.38
49: ๐ณ๐ฑ NL 4.2
50: ๐ฑ๐ฎ LI 3.94
๐ Global leaderboard by doses administered per 100 people in the total population
๐ Global leaderboard by doses administered per 100 people in the total population
61: ๐จ๐ท CR 1.9
62: ๐ธ๐ญ SH 1.76
63: ๐ถ๐ฆ QA 1.74
64: ๐ง๐ฌ BG 1.5
65: ๐ฆ๐ท AR 1.48
66: ๐ธ๐ฆ SA 1.44
67: ๐ฒ๐ฝ MX 1.22
68: ๐ง๐ฉ BD 1.12
69: ๐ฑ๐ฐ LK 1.09
70: ๐ต๐ฆ PA 0.84
๐ Global leaderboard by doses administered per 100 people in the total population
71: ๐ฎ๐ณ IN 0.78
72: ๐ฎ๐ฉ ID 0.65
73: ๐ฆ๐ฟ AZ 0.64
74: ๐ณ๐ต NP 0.54
75: ๐ต๐ช PE 0.43
76: ๐ฒ๐ด MO 0.31
77: ๐ฒ๐ฒ MM 0.19
78: ๐ฉ๐ฟ DZ 0.17
79: ๐ฆ๐ฑ AL 0.11
80: ๐ง๐ด BO 0.09
๐ Global leaderboard by doses administered per 100 people in the total population
81: ๐ฌ๐พ GY 0.08
82: ๐ช๐จ EC 0.05
83: ๐จ๐ด CO 0.04
84: ๐ฐ๐ญ KH 0.02
85: ๐ต๐ฐ PK 0.02
86: ๐ฒ๐บ MU 0.02
87: ๐ฟ๐ฆ ZA 0.01
88: ๐ฎ๐ท IR 0.01
๐ Global leaderboard by total vaccinations performed
01: ๐บ๐ธ US 59.6M
02: ๐จ๐ณ CN 40.5M
03: ๐ฌ๐ง GB 17.5M
04: ๐ฎ๐ณ IN 10.7M
05: ๐ฎ๐ฑ IL 7.13M
06: ๐ง๐ท BR 6.54M
07: ๐น๐ท TR 6.36M
08: ๐ฆ๐ช AE 5.47M
09: ๐ฉ๐ช DE 4.72M
10: ๐ท๐บ RU 3.9M
๐ Global leaderboard by total vaccinations performed
11: ๐ซ๐ท FR 3.51M
12: ๐ฎ๐น IT 3.39M
13: ๐ช๐ธ ES 2.94M
14: ๐ต๐ฑ PL 2.56M
15: ๐จ๐ฑ CL 2.38M
16: ๐ฒ๐ฆ MA 2.36M
17: ๐ง๐ฉ BD 1.85M
18: ๐ท๐ธ RS 1.81M
19: ๐ฎ๐ฉ ID 1.79M
20: ๐ฒ๐ฝ MX 1.57M
๐ Global leaderboard by total vaccinations performed
21: ๐จ๐ฆ CA 1.4M
22: ๐ท๐ด RO 1.32M
23: ๐ณ๐ฑ NL 720K
24: ๐ฆ๐ท AR 669K
25: ๐ฌ๐ท GR 664K
26: ๐ง๐ช BE 631K
27: ๐ต๐น PT 619K
28: ๐จ๐ญ CH 612K
29: ๐ธ๐ช SE 586K
30: ๐ญ๐บ HU 544K
๐ Global leaderboard by total vaccinations performed
31: ๐จ๐ฟ CZ 538K
32: ๐ธ๐ฆ SA 502K
33: ๐ฉ๐ฐ DK 459K
34: ๐ณ๐ด NO 372K
35: ๐ธ๐ฐ SK 344K
36: ๐ซ๐ฎ FI 334K
37: ๐ฎ๐ช IE 294K
38: ๐ง๐ญ BH 268K
39: ๐ธ๐ฌ SG 256K
40: ๐ฑ๐ฐ LK 233K
๐ Global leaderboard by total vaccinations performed
41: ๐ฑ๐น LT 187K
42: ๐ณ๐ต NP 158K
43: ๐ด๐ฒ OM 158K
44: ๐ญ๐ท HR 142K
45: ๐ต๐ช PE 142K
46: ๐ฐ๐ผ KW 137K
47: ๐ธ๐ฎ SI 135K
48: ๐ง๐ฌ BG 104K
49: ๐ฒ๐ฒ MM 103K
50: ๐จ๐ท CR 96.9K
๐ Global leaderboard by total vaccinations performed
๐ Global leaderboard by total vaccinations performed
61: ๐ต๐ฆ PA 36.1K
62: ๐ฑ๐บ LU 28.9K
63: ๐ฌ๐ฎ GI 28.8K
64: ๐ฏ๐ช JE 26K
65: ๐ฎ๐ธ IS 25.7K
66: ๐จ๐ด CO 21.3K
67: ๐ฐ๐พ KY 17.3K
68: ๐ฎ๐ฒ IM 17.2K
69: ๐ฌ๐ฌ GG 15.1K
70: ๐ง๐ฒ BM 13.2K
๐ Global leaderboard by total vaccinations performed
71: ๐ง๐ด BO 10.2K
72: ๐ฎ๐ท IR 10K
73: ๐ง๐ง BB 9.12K
74: ๐ช๐จ EC 8.19K
75: ๐ฟ๐ฆ ZA 6.52K
76: ๐น๐จ TC 6.43K
77: ๐ซ๐ด FO 5.36K
78: ๐ฏ๐ต JP 5.04K
79: ๐ฐ๐ญ KH 3.24K
80: ๐ฆ๐ฑ AL 3.05K
๐ Global leaderboard by total vaccinations performed
81: ๐ฌ๐ฑ GL 2.58K
82: ๐ฒ๐จ MC 2.4K
83: ๐ฒ๐ด MO 2K
84: ๐ฆ๐ฉ AD 1.62K
85: ๐ฑ๐ฎ LI 1.5K
86: ๐ฆ๐ฎ AI 1.34K
87: ๐ช๐ฌ EG 1.32K
88: ๐ฌ๐พ GY 668
๐ Global leaderboard by total vaccinations performed
๐งช Vaccines used globally
Covaxin:
๐ฎ๐ณ IN
๐งช Vaccines used globally
Johnson&Johnson:
๐ฟ๐ฆ ZA
๐งช Vaccines used globally
Moderna:
๐ฆ๐น AT ๐ง๐ช BE ๐ง๐ฌ BG ๐จ๐ฆ CA ๐จ๐ญ CH ๐จ๐ฟ CZ ๐ฉ๐ช DE ๐ฉ๐ฐ DK ๐ช๐ธ ES ๐ช๐ช EE ๐ซ๐ฎ FI ๐ซ๐ท FR ๐ฌ๐ท GR ๐ฎ๐ช IE ๐ฎ๐ธ IS ๐ฎ๐ฑ IL ๐ฎ๐น IT ๐ฑ๐ฎ LI ๐ฑ๐น LT ๐ฑ๐บ LU ๐ฑ๐ป LV ๐ณ๐ฑ NL ๐ณ๐ด NO ๐ต๐ฑ PL ๐ต๐น PT ๐ท๐ด RO ๐บ๐ธ US
๐งช Vaccines used globally
Oxford/AstraZeneca:
๐ฆ๐ฎ AI ๐ฆ๐ช AE ๐ฆ๐น AT ๐ฆ๐ฟ AZ ๐ง๐ช BE ๐ง๐ฉ BD ๐ง๐ฌ BG ๐ง๐ท BR ๐ง๐ง BB ๐จ๐ฟ CZ ๐ฉ๐ช DE ๐ฉ๐ด DO ๐ช๐ธ ES ๐ช๐ช EE ๐ซ๐ฎ FI ๐ซ๐ท FR ๐ฌ๐ง GB ๐ฌ๐ท GR ๐ฌ๐พ GY ๐ฎ๐ฒ IM ๐ฎ๐ณ IN ๐ฎ๐ช IE ๐ฎ๐ธ IS ๐ฎ๐น IT ๐ฏ๐ช JE ๐ฑ๐ฐ LK ๐ฑ๐น LT ๐ฑ๐บ LU ๐ฑ๐ป LV ๐ฒ๐ฆ MA ๐ฒ๐ป MV ๐ฒ๐ฝ MX ๐ฒ๐ฒ MM ๐ฒ๐บ MU ๐ณ๐ฑ NL
๐งช Vaccines used globally
Oxford/AstraZeneca (contd.):
๐ณ๐ด NO ๐ณ๐ต NP ๐ด๐ฒ OM ๐ต๐ฐ PK ๐ต๐ฑ PL ๐ท๐ด RO ๐ธ๐ญ SH ๐ธ๐ฎ SI ๐ธ๐ช SE ๐ธ๐จ SC
๐งช Vaccines used globally
Pfizer/BioNTech:
๐ฆ๐ฑ AL ๐ฆ๐ฉ AD ๐ฆ๐ช AE ๐ฆ๐น AT ๐ง๐ช BE ๐ง๐ฌ BG ๐ง๐ญ BH ๐ง๐ฒ BM ๐จ๐ฆ CA ๐จ๐ญ CH ๐จ๐ฑ CL ๐จ๐ด CO ๐จ๐ท CR ๐ฐ๐พ KY ๐จ๐พ CY ๐จ๐ฟ CZ ๐ฉ๐ช DE ๐ฉ๐ฐ DK ๐ช๐จ EC ๐ช๐ธ ES ๐ช๐ช EE ๐ซ๐ฎ FI ๐ซ๐ท FR ๐ซ๐ด FO ๐ฌ๐ง GB ๐ฌ๐ฌ GG ๐ฌ๐ฎ GI ๐ฌ๐ท GR ๐ฌ๐ฑ GL ๐ญ๐ท HR ๐ญ๐บ HU ๐ฎ๐ฒ IM ๐ฎ๐ช IE ๐ฎ๐ธ IS ๐ฎ๐ฑ IL ๐ฎ๐น IT
๐งช Vaccines used globally
Pfizer/BioNTech (contd.):
๐ฏ๐ช JE ๐ฏ๐ต JP ๐ฐ๐ผ KW ๐ฑ๐ฎ LI ๐ฑ๐น LT ๐ฑ๐บ LU ๐ฑ๐ป LV ๐ฒ๐จ MC ๐ฒ๐ฝ MX ๐ฒ๐น MT ๐ณ๐ฑ NL ๐ณ๐ด NO ๐ด๐ฒ OM ๐ต๐ฆ PA ๐ต๐ฑ PL ๐ต๐น PT ๐ถ๐ฆ QA ๐ท๐ด RO ๐ธ๐ฆ SA ๐ธ๐ฌ SG ๐ท๐ธ RS ๐ธ๐ฐ SK ๐ธ๐ฎ SI ๐ธ๐ช SE ๐น๐จ TC ๐บ๐ธ US
๐งช Vaccines used globally
Sinopharm/Beijing:
๐ฆ๐ช AE ๐ง๐ญ BH ๐จ๐ณ CN ๐ช๐ฌ EG ๐ฐ๐ญ KH ๐ฒ๐ด MO ๐ฒ๐ฆ MA ๐ต๐ฐ PK ๐ต๐ช PE ๐ท๐ธ RS ๐ธ๐จ SC
Most of the vaccines in use globally require two doses. Doses administered per 100 people in the total population can not be converted to an accurate percentage easily due to differences in vaccines and/or datasets.
Most of the vaccines in use globally require two doses. Doses administered per 100 people in the total population can not be converted to an accurate percentage easily due to differences in vaccines and/or datasets.
Most of the vaccines in use globally require two doses. Doses administered per 100 people in the total population can not be converted to an accurate percentage easily due to differences in vaccines and/or datasets.
Most of the vaccines in use globally require two doses. Doses administered per 100 people in the total population can not be converted to an accurate percentage easily due to differences in vaccines and/or datasets.
Most of the vaccines in use globally require two doses. Doses administered per 100 people in the total population can not be converted to an accurate percentage easily due to differences in vaccines and/or datasets.
Most of the vaccines in use globally require two doses. Doses administered per 100 people in the total population can not be converted to an accurate percentage easily due to differences in vaccines and/or datasets.